Preclinical and clinical research and development management during Phase I through Phase III. Experienced with multiple pharmaceutical compounds: Monoclonal antibodies, protein hormones, and small molecule drugs. Skilled in several therapeutic areas with a focus in oncology, CNS disorders and infectious diseases.
Since 2013, project management of drug product and process development of a combination product (monoclonal antibody and three drug delivery devices) during commercial technology transfer and preparing pre-approval inspection readiness and supplying clinical Phase III trials. Known as deliberative, methodical, and conscientious. Fluent in German and English.
Goals: Advance pha...
We鈥檝e updated our privacy policy so that we are compliant with changing global privacy regulations and to provide you with insight into the limited ways in which we use your data.
You can read the details below. By accepting, you agree to the updated privacy policy.
